Primary Record
suxibuzone
- In stock
- 7,848 g
- Purity
- 99.8 %
- CAS
- 27470-51-5
Compound Identifiers & Properties
- CAS
- 27470-51-5
- PubChem CID
- 5362
- SMILES
- CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O
- Canonical SMILES
- CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O
Names & Synonyms
- suxibuzone
- Suxibuzona
- Calibene
- Danilon
- Flogos
- Suxibuzonum
- Solurol
- Flamilon
- Aflogan
- Alfide
- suxibutazone
- 27470-51-5
- Suxibuzon
- Suxibuzone CRS
- Prestwick_113
- Suxibuzonum [INN-Latin]
- Suxibuzona [INN-Spanish]
- Suxibuzone [INN:JAN]
- Suxibuzone (Standard)
- 86TDZ5WP2B
- Spectrum_000321
- 4-Hydroxymethylbutazolidine hemisuccinate
- UNII-86TDZ5WP2B
- AE-17
- DTXSID6021296
- Suxibuzone (JAN/INN)
- AC1Q5VSO
- SUXIBUZONE [INN]
- SUXIBUZONE [JAN]
- Prestwick0_000658
- Prestwick1_000658
- Prestwick2_000658
- Prestwick3_000658
- RefChem:890070
- Spectrum2_000966
- Spectrum3_000664
- Spectrum4_000433
- Spectrum5_001113
- C24H26N2O6
- Suxibuzone [INN:BAN:JAN]
- CHEBI:32173
- Epitope ID:124941
- AC1L1K6N
- SUXIBUZONE [MART.]
- DTXCID601296
- ONWXNHPOAGOMTG-UHFFFAOYSA-N
- AE 17
- SUXIBUZONE [WHO-DD]
- SCHEMBL25810
- BSPBio_000695
- BSPBio_002327
- KBioGR_000786
- KBioSS_000801
- MLS002153938
- DivK1c_000171
- NSC-757866
- SPECTRUM1501157
- EINECS 248-477-6
- SPBio_000971
- SPBio_002616
- BPBio1_000765
- orb1710722
- CHEMBL1414320
- SUXIBUZONE [EP IMPURITY]
- CTK4F9751
- HMS500I13
- HY-B1079R
- KBio1_000171
- KBio2_000801
- KBio2_003369
- KBio2_005937
- KBio3_001547
- BRD5826
- BRN 0904563
- CID5362
- M02AA22
- SUXIBUZONE [EP MONOGRAPH]
- MFCD00079562
- NINDS_000171
- HMS1570C17
- HMS1923I17
- HMS2097C17
- HMS2232E17
- HMS3371A12
- HMS3714C17
- HMS5083M15
- Pharmakon1600-01501157
- 4-((4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy)-4-oxobutanoic acid
- BRD-5826
- CID:5362
- HY-B1079
- ZINC3875039
- Tox21_110615
- Tox21_202352
- Tox21_302778
- AR-1F9199
- CCG-40180
- NCGC00016799-01
- NSC757866
- AKOS024374988
- C24-H26-N2-O6
- Tox21_110615_1
- 4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
- CS-4635
- DB13232
- NSC 757866
- CAS-27470-51-5
- IDI1_000171
- NCGC00016799-02
- NCGC00016799-03
- NCGC00016799-04
- NCGC00016799-05
- NCGC00016799-06
- NCGC00016799-08
- NCGC00095261-01
- NCGC00095261-02
- NCGC00095261-03
- NCGC00095261-04
- NCGC00256470-01
- NCGC00259901-01
- J10.731J
- MS-27855
- SMR001233279
- 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate
- SBI-0051667.P002
- SID:134223485
- DB-047228
- LS-147486
- 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]
- AB00052229
- FT-0630533
- NS00008152
- ST51015119
- X6836
- D01289
- F85232
- AB00052229_08
- AB00052229_09
- 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester)
- 470S515
- A936730
- C003371
- SR-01000841241
- Q7650623
- SR-01000841241-2
- SR-01000841241-3
- BRD-K78815826-001-05-4
- BRD-K78815826-001-08-8
- BRD-K78815826-001-13-8
- BRD-K78815826-001-14-6
- Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- 1,2-Diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine Hemisuccinate
- 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester)
- 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure
- Suxibuzone, European Pharmacopoeia (EP) Reference Standard
- 4-{[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl]oxy}-4-oxobutanoic acid
- 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONEHYDROGENSUCCINATE[ESTER]
- Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester
- Butanedioic acid, mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- 28277-71-6
- 3-(1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine-4-ylmethoxycarbonyl)propionic acid
- 4-[(4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxy]-4-oxobutanoic acid
- 4-[(4-butyl-3,5-dioxo-1,2-diphenyl-pyrazolidin-4-yl)methoxy]-4-oxo-butanoic acid
- 4-Butyl-4-(.beta.-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- Butanedioic acid mono-nu[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- Butanedioic acid,1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- Succinic acid hydrogen (1,2-diphenyl-3,5-dioxo-4-butylpyrazolidin-4-yl)methyl ester
- Succinic acid hydrogen (4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl ester
- Succinic acid hydrogen 1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- succinic acid monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- Suxibuzone; 4-[(4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
- 248-477-6
- 3-{[(4-butyl-3,5-dioxo-1,2-diphenyl-1,2-diazolidin-4-yl)methyl]oxycarbonyl}pro panoic acid
- SB